T1	Participants 812 925	Three hundred consecutive patients scheduled for US-guided TPB were randomized 1:1:1 to receive PI administration
T2	Participants 974 982	(Group 1
T3	Participants 1084 1091	Group 2
T4	Participants 1164 1172	(Group 3
T5	Participants 1443 1463	Four (1.3%) patients
T6	Participants 1535 1559	Group 1 with 98 patients
T7	Participants 1561 1576	Group 2 with 99
T8	Participants 1582 1597	Group 3 with 99
T9	Participants 1603 1611	3 groups
T10	Participants 2295 2304	3 groups.
T11	Participants 2549 2557	patients
